000291691 001__ 291691
000291691 005__ 20241215014305.0
000291691 0247_ $$2doi$$a10.1093/jnci/djae172
000291691 0247_ $$2pmid$$apmid:39018167
000291691 0247_ $$2ISSN$$a0027-8874
000291691 0247_ $$2ISSN$$a1460-2105
000291691 0247_ $$2ISSN$$a1475-4029
000291691 0247_ $$2altmetric$$aaltmetric:165561508
000291691 037__ $$aDKFZ-2024-01495
000291691 041__ $$aEnglish
000291691 082__ $$a610
000291691 1001_ $$aHurson, Amber N$$b0
000291691 245__ $$aRisk factors for breast cancer subtypes by race and ethnicity: A scoping review.
000291691 260__ $$aOxford$$bOxford Univ. Press$$c2024
000291691 3367_ $$2DRIVER$$aarticle
000291691 3367_ $$2DataCite$$aOutput Types/Journal article
000291691 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1733990114_31422$$xReview Article
000291691 3367_ $$2BibTeX$$aARTICLE
000291691 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000291691 3367_ $$00$$2EndNote$$aJournal Article
000291691 500__ $$a2024 Dec 1;116(12):1992-2002
000291691 520__ $$aBreast cancer is comprised of distinct molecular subtypes. Studies have reported differences in risk factor associations with breast cancer subtypes, especially by tumor estrogen receptor (ER) status, but their consistency across racial and ethnic populations has not been comprehensively evaluated.We conducted a qualitative, scoping literature review using the Preferred Reporting Items for Systematic Reviews and Meta-analysis, extension for Scoping Reviews to investigate consistencies in associations between 18 breast cancer risk factors (reproductive, anthropometric, lifestyle, and medical history) and risk of ER-defined subtypes in women who self-identify as Asian, Black or African American, Hispanic or Latina, or White. We reviewed publications between January 1, 1990 and July 1, 2022. Etiologic heterogeneity evidence (convincing, suggestive, none, or inconclusive) was determined by expert consensus.Publications per risk factor ranged from 14 (benign breast disease history) to 66 (parity). Publications were most abundant for White women, followed by Asian, Black or African American, and Hispanic or Latina women. Etiologic heterogeneity evidence was strongest for parity, followed by age at first birth, post-menopausal BMI, oral contraceptive use, and estrogen-only and combined menopausal hormone therapy. Evidence was limited for other risk factors. Findings were consistent across racial and ethnic groups, although the strength of evidence varied.The literature supports etiologic heterogeneity by ER for some established risk factors that are consistent across race and ethnicity groups. However, in non-White populations evidence is limited. Larger, more comparable data in diverse populations is needed to better characterize breast cancer etiologic heterogeneity.
000291691 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000291691 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000291691 7001_ $$aAhearn, Thomas U$$b1
000291691 7001_ $$aKoka, Hela$$b2
000291691 7001_ $$aJenkins, Brittany D$$b3
000291691 7001_ $$aHarris, Alexandra R$$b4
000291691 7001_ $$aRoberts, Sylvia$$b5
000291691 7001_ $$aFan, Sharon$$b6
000291691 7001_ $$aFranklin, Jamirra$$b7
000291691 7001_ $$aButera, Gisela$$b8
000291691 7001_ $$aKeeman, Renske$$b9
000291691 7001_ $$0P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9$$aJung, Audrey Ying-Chee$$b10
000291691 7001_ $$aMiddha, Pooja$$b11
000291691 7001_ $$aGierach, Gretchen L$$b12
000291691 7001_ $$aYang, Xiaohong R$$b13
000291691 7001_ $$0P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aChang-Claude, Jenny$$b14$$udkfz
000291691 7001_ $$aTamimi, Rulla M$$b15
000291691 7001_ $$aTroester, Melissa A$$b16
000291691 7001_ $$aBandera, Elisa V$$b17
000291691 7001_ $$aAbubakar, Mustapha$$b18
000291691 7001_ $$aSchmidt, Marjanka K$$b19
000291691 7001_ $$aGarcia-Closas, Montserrat$$b20
000291691 773__ $$0PERI:(DE-600)1465951-7$$a10.1093/jnci/djae172$$gp. djae172$$n12$$p1992-2002$$tJournal of the National Cancer Institute$$v116$$x0027-8874$$y2024
000291691 909CO $$ooai:inrepo02.dkfz.de:291691$$pVDB
000291691 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000291691 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000291691 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000291691 9141_ $$y2024
000291691 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000291691 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJNCI-J NATL CANCER I : 2022$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-21
000291691 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bJNCI-J NATL CANCER I : 2022$$d2023-10-21
000291691 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000291691 980__ $$ajournal
000291691 980__ $$aVDB
000291691 980__ $$aI:(DE-He78)C020-20160331
000291691 980__ $$aUNRESTRICTED